سعر هيدروكورتيزون روسيل 10 مجم 25 قرص 2026

Hydrocortisone 10 mg scored tablets (French product) listed in Egyptian directories as an illegal import with no Egyptian price; used as glucocorticoid replacement therapy in adrenal insufficiency.

• Glucocorticoid replacement therapy in adrenal insufficiency: primary (Addison disease, adrenalectomy), pituitary-origin (e.g. Sheehan syndrome) and congenital adrenal hyperplasia with or without salt wasting.ANSM - Base de Données Publique des Médicaments (France)

• Frequency not known: fluid retention, hypokalaemia, hyperglycaemia/reduced glucose tolerance, Cushing syndrome, psychiatric disorders, peptic ulcer, osteoporosis, myopathy, skin atrophy, blurred vision/cataract/glaucoma, hypersensitivity; under-dosing may cause asthenia, orthostatic hypotension and hyperkalaemia.International label, same product · ANSM - Base de Données Publique des Médicaments (France)

• Hypersensitivity to hydrocortisone or excipients; untreated bacterial, viral, tuberculous or fungal infection; live attenuated vaccines when used at immunosuppressive doses or long term (not applicable to emergency/cortisol-deficiency replacement).International label, same product · ANSM - Base de Données Publique des Médicaments (France)

• At replacement doses the usual corticosteroid precautions are generally not required; maintain electrolyte balance and a normal-salt diet; never interrupt replacement therapy.International label, same product · ANSM - Base de Données Publique des Médicaments (France)
• Higher doses can cause infection risk, visual disturbance (cataract, glaucoma, central serous chorioretinopathy), psychiatric effects, pheochromocytoma crisis, tendon rupture (especially with fluoroquinolones), tumour lysis syndrome in haematological malignancy and growth retardation in children.International label, same product · ANSM - Base de Données Publique des Médicaments (France)
• Contains lactose; not for patients with galactose intolerance, total lactase deficiency or glucose-galactose malabsorption.International label, same product · ANSM - Base de Données Publique des Médicaments (France)

• Live attenuated vaccinesNot recommended (risk of generalised, potentially fatal vaccine disease).ANSM - Base de Données Publique des Médicaments (France)
• Enzyme inducersReduced hydrocortisone efficacy through increased metabolism; particularly serious in replacement therapy - adjust dose during and after the inducer.ANSM - Base de Données Publique des Médicaments (France)
• CYP3A inhibitors (including cobicistat-containing products)May increase systemic corticosteroid adverse effects; avoid unless benefit outweighs risk.ANSM - Base de Données Publique des Médicaments (France)

• Use in pregnancy only if maternal benefit outweighs risks; maternal adrenal insufficiency must be treated, adjusting the dose clinically. Teratogenic in animals (cleft palate).International label, same product · ANSM - Base de Données Publique des Médicaments (France)
• Hydrocortisone is excreted in breast milk; breastfeeding is not recommended.International label, same product · ANSM - Base de Données Publique des Médicaments (France)

English text not available for this section.